Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Amortizatization of Intangibles (2016 - 2025)

Standard Biotools (LAB) has disclosed Amortizatization of Intangibles for 15 consecutive years, with $144000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 79.75% to $144000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.5 million, a 43.48% decrease, with the full-year FY2024 number at $4.3 million, up 244.65% from a year prior.
  • Amortizatization of Intangibles was $144000.0 for Q3 2025 at Standard Biotools, down from $730000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $11.5 million in Q4 2021 to a low of -$5.6 million in Q3 2021.
  • A 5-year average of $1.4 million and a median of $890500.0 in 2023 define the central range for Amortizatization of Intangibles.
  • Biggest YoY gain for Amortizatization of Intangibles was 685.0% in 2021; the steepest drop was 1149.81% in 2021.
  • Standard Biotools' Amortizatization of Intangibles stood at $11.5 million in 2021, then plummeted by 74.28% to $3.0 million in 2022, then tumbled by 68.33% to $940000.0 in 2023, then fell by 13.51% to $813000.0 in 2024, then crashed by 82.29% to $144000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Amortizatization of Intangibles are $144000.0 (Q3 2025), $730000.0 (Q2 2025), and $841000.0 (Q1 2025).